A B S T R A C T Marrow grafts were carried out between 16 canine sibling donor-recipient pairs. The pairs were matched by serological histocompatibility testing and were nonreactive in a one-way mixed leukocyte culture.
INTRODUCTION
The dog has been used as a model for studies of histocompatibility and marrow grafting in a randomly bred species. In initial studies, serological histocompatibility typing with a small panel of lymphocytotoxic antisera was used to select canine donor-recipient pairs for grafting. Clearly, the degree of matching with these antisera appeared to be an important determinant of Received for publication 28 December 1970. marrow graft rejection, development of a lethal graftversus-host (GVH)1 disease or eventual survival of the recipient after infusion of allogeneic marrow (1) (2) (3) .
Studies of serological histocompatibility typing in man have resulted in the recognition of a number of human histocompatibility or HL-A antigens (4) . Despite polymorphism of the HL-A system, one can find HL-Aidentical individuals among siblings because there are only four possible combinations of the parental haplotypes. More recently, family studies were conducted in which a one-way mixed leukocyte culture test (MLC) and serological typing were correlated (5). It was found that HL-A disparity caused stimulation in MLC while HL-A identity resulted in nonreactivity.
In some cases HL-A identity cannot be established by serotyping alone as insufficient family members are available for haplotype analysis. In these cases HL-A identity is verified by nonreactivity in MLC (5) .
In the dog also, a good correlation has been found between serotyping and the results in MLC (6) . Thus, canine sibling pairs matched for serologically detectable histocompatibility antigens and nonreactive in MLC make an excellent randomly bred animal model for marrow grafting experiments that may be applicable to HL-Amatched human siblings. This report presents the results of marrow grafting between 16 such canine sibling pairs.
METHODS
Pairs of canine siblings, 6-12 months of age and weighing 5-30 kg, were observed for 2 months for disease. They were typed for canine red cell antigen A (7), dewormed, and immunized against distemper and hepatitis. Each pair was selected on the basis of matching with eight canine lymphocytotoxic antisera. testing technique and data on the usefulness of the sera in selecting donor-recipient pairs for organ grafting have been described (1-3, 8, 9) . Lymphocytes of all sibling pairs were tested in a one-way MLC (6) . The published MLC method was altered in three respects: (a) the cells were cultured in Waymouth medium,2 (b) a final concentration of 100 stimulating leukocytes per milliliter was used, and (c) each culture was exposed to 3H-thymidine for 17 hr after 7 days of incubation at 370C. Of 58 canine sibling pairs recently matched by serotyping in this laboratory, 43 were found to be nonreactive in MLC. Only pairs that were matched by serotyping and nonreactive in MLC were used in the present study. One member of each pair served as the marrow donor and the other as the marrow recipient.
Recipients were prepared for grafting by 1500-1580 R (midline air exposure) of whole body irradiation from two opposing 0'Co sources at a rate of 5.3 R/min. This corresponded to a midbody exposure of approximately 1200-1300 rads (10) .
Donors were killed with pentobarbital sodium and marrow was then removed from all major bones and prepared for intravenous infusion (11) . Donor marrow was infused within 4 hr of irradiation of the recipient.
Recipients were given parenteral fluids, electrolytes, and antibiotic therapy when clinically indicated. No immunosuppressive drugs were given after grafting. Peripheral blood cell counts were obtained at least three times weekly. Prompt rises in white blood cell and platelet counts after the postirradiation decline and histologic evidence of marrow repopulation were used as criteria for marrow engraftment. Other criteria were the development of a lethal GVH disease, the demonstration of a donor sex chromosome pattern in cells from marrow and peripheral blood, or a change to donor red cell type. Details of the cytogenetic technique have been described (12) . Only cells with 78 chromosomes were evaluated. Complete autopsies were carried out on all recipients that died. Table I summarizes data on the 16 recipients. Table II presents the MLC results. The activity in counts per minute represents means of duplicate cultures. Reproducibility was such that the average deviation of a duplicate from its mean was 13.8%. Each value represents the response of lymphocytes from a given dog to stimulation by irradiated leukocytes from that dog (autologous control), his sibling, and an unrelated control. The unrelated controls were included to be sure that the responding cells were functionally intact, and in most cases consisted of a mixture of irradiated cells from three unrelated dogs. In four cases this control consisted of irradiated human cells.
RESULTS
All 16 dogs showed prompt marrow engraftment as indicated by rising white blood cell (Fig. 1) and platelet counts after the postirradiation decline. None of the 16 rejected the graft. 9 of the 16 died (Table I) Da)ys FIGURE 1 White blood cell changes (average) in 16 canine recipients given 1500-1580 R total body irradiation followed by marrow from histocompatible siblings. The shaded area represents the range. 
DISCUSSION
A number of canine recipients in the present study died with GVH disease despite matching of the sibling pairs by serological histocompatibility testing and MLC.
The high incidence of lethal GVH disease must be explained on the basis of "minor" histocompatibility differences undetected by currently employed in vitro typing techniques. The GVH disease in the matched siblings differed from that seen in dogs given grafts from mismatched donors in that it occurred between the 2nd and 4th month after grafting, and it's onset and course appeared to be more chronic. Mismatched dogs uniformly succumbed to violent GVH disease within 21 days of grafting (17) .
Three matched siblings showed a combination of lymphoid atrophy and pneumonia in the absence of other findings of GVH disease at the time of autopsy. Lymphoid atrophy has been observed in other animal species after allogeneic marrow grafting (18, 19) and has been related to destruction of donor lymphoid cells ("allergic death") caused by an excess of host antigens (20, 21) . Lymphoid atrophy, therefore, may be a consequence of GVH disease and it may explain the impairment of immunological defense against pathogens observed in animals with allogeneic marrow grafts (11, 19) .
Recently, the effectiveness of the immunosuppressive drug methotrexate for control of canine GVH disease was demonstrated using unrelated donor-recipient pairs with known histoincompatibility. The acute form of GVH disease has been controlled and long-term survival for over 600 days has been achieved in some recipients when intensive methotrexate therapy was begun immediately after marrow grafting and continued for 102 days (15) . Cyclophosphamide proved to be ineffective in preventing rapidly fatal GVH disease in this incompatible combination (16) . The present study underscores the need for immunosuppressive therapy after marrow grafting even in "compatible" siblings. Since methotrexate was effective in ameliorating GVH disease in incompatible recipients, we presume that it would be effective for these compatible siblings. Canine sibling pairs, matched by serotyping and by MLC in a manner similar to that used to define human HL-A-matched siblings, appear to offer an excellent model in a randomly bred species for evaluation of the optimal dose and schedule of methotrexate and other promising agents.
